文献
J-GLOBAL ID:201802245742292240
整理番号:18A1053069
進行性固形腫瘍またはホルモン受容体陽性進行性乳癌の日本人患者におけるタセリシブの第I相試験
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancer
著者 (14件):
Tamura Kenji
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Kodaira Makoto
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Shimizu Chikako
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Yonemori Kan
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Yunokawa Mayu
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Shimomura Akihiko
(Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan)
,
Kobayashi Takayuki
(Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Nakano Kenji
(Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Tomomatsu Junichi
(Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Ito Yoshinori
(Department of Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
,
Tanaka Jun
(Chugai Pharmaceutical Co., Ltd, Tokyo, Japan)
,
Kuriki Hiroshi
(Chugai Pharmaceutical Co., Ltd, Tokyo, Japan)
,
Gu Zhaodi
(Chugai Pharmaceutical Co., Ltd, Tokyo, Japan)
,
Takahashi Shunji
(Department of Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan)
資料名:
Cancer Science (Web)
(Cancer Science (Web))
巻:
109
号:
5
ページ:
1592-1601
発行年:
2018年
JST資料番号:
U0505A
ISSN:
1349-7006
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)